Synopsys is rated Buy with a target price of $389, driven by its strategic acquisition of Ansys and its plan to monetize multiple stages of the chip lifecycle. The company aims to increase revenue per chip through integrated design and simulation, custom silicon royalties, and future AI agent applications, although some revenue streams are still unproven. Revenue growth for fiscal year 2026 is expected to be largely acquisition-driven, with a low free cash flow yield of 2.7% and elevated debt following the Ansys acquisition. The stock's valuation is attractive at 22.5 times estimated 2027 earnings, but future gains depend on successful integration, margin improvements, and realization of new revenue sources.
